Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$18.8M Buy
60,000
+8,200
+16% +$2.43M 0.32% 26
2017
Q2
$14.1M Buy
51,800
+33,000
+176% +$8.73M 0.28% 37
2017
Q1
$5.14M Buy
18,800
+5,100
+37% +$1.44M 0.17% 91
2016
Q4
$3.88M Sell
13,700
-9,900
-42% -$2.93M 0.09% 276
2016
Q3
$7.39M Sell
23,600
-12,800
-35% -$3.79M 0.15% 137
2016
Q2
$8.8M Sell
36,400
-300
-0.8% -$79.1K 0.15% 135
2016
Q1
$9.55M Buy
36,700
+11,500
+46% +$3.04M 0.17% 131
2015
Q4
$7.72M Buy
25,200
+7,700
+44% +$2.21M 0.08% 329
2015
Q3
$5.11M Buy
17,500
+5,700
+48% +$1.88M 0.05% 505
2015
Q2
$4.77M Sell
11,800
-4,100
-26% -$1.65M 0.04% 589
2015
Q1
$6.71M Sell
15,900
-15,100
-49% -$5.95M 0.07% 399
2014
Q4
$10.5M Buy
31,000
+15,100
+95% +$4.89M 0.07% 386
2014
Q3
$5.26M Sell
15,900
-2,600
-14% -$857K 0.03% 911
2014
Q2
$5.83M Buy
18,500
+7,200
+64% +$2.17M 0.03% 861
2014
Q1
$3.46M Sell
11,300
-19,100
-63% -$6.06M 0.02% 1077
2013
Q4
$8.5M Sell
30,400
-23,000
-43% -$5.95M 0.05% 532
2013
Q3
$12.9M Buy
53,400
+19,100
+56% +$4.27M 0.08% 276
2013
Q2
$7.38M Buy
+34,300
New +$7.33M 0.04% 507

Other funds holding BIIB

Spot Trading's BIIB Position: Q3 2017 in Review

Spot Trading sold out of Biogen (BIIB) in Q3 2017, closing a stake of 9,193 shares — an estimated $2.72M sold.

Spot Trading first reported a position in BIIB in Q4 2013 and held it in 12 quarters. The position peaked at $8.26M in Q1 2016. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Spot Trading reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 9,193 Biogen shares in Q3 2017, an estimated $2.72M.
  • Spot Trading first reported a position in Biogen in Q4 2013 and held it in 12 quarters.
  • Spot Trading's Biogen position peaked at $8.26M in Q1 2016.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.